LEXARIA BIOSCIENCE CORP. Income (Loss) from Continuing Operations, Per Basic Share
LEXARIA BIOSCIENCE CORP. (LEXX) reported Income (Loss) from Continuing Operations, Per Basic Share of -$0.07 per share for the 10-month period ending 2014-08-31, per its 10-KT filed 2014-12-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2014-12-09
- 2014-08-31: Income (Loss) from Continuing Operations, Per Basic Share 10 month -$0.07.
- 2013-10-31: Income (Loss) from Continuing Operations, Per Basic Share 2 month -$0.04.
- 2013-08-31: Income (Loss) from Continuing Operations, Per Basic Share 10 month -$0.03.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 2 month | Income (Loss) from Continuing Operations, Per Basic Share 10 month |
|---|---|---|
| 2014-08-31 | -$0.07 10-KT · filed 2014-12-09 | |
| 2013-10-31 | -$0.04 10-KT · filed 2014-12-09 | |
| 2013-08-31 | -$0.03 10-KT · filed 2014-12-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |